Showing results (2101-2110 of 2,492) with videos related to

Sort By:
Pageof 250
JTO Clinical and Research Reports|January 10, 2022
A Phase 1b Study of Telisotuzumab Vedotin in Combination With Nivolumab in Patients With NSCLCD Ross Camidge, Fabrice Barlesi, Jonathan W Goldman, et al.
Cardiovascular Diagnosis and Therapy|May 10, 2021
Systematic assessment of health care perception in adults with congenital heart disease in GermanyRhoia Neidenbach, Stephan Achenbach, Caroline Andonian, et al.
Bioorganic & Medicinal Chemistry Letters|July 1, 2004
Parallel synthesis and structure-activity relationships of a series of highly potent, selective, and neutral factor Xa inhibitorsShawn M Bauer, Erick A Goldman, Wenrong Huang, et al.
Allergy|February 28, 2009
Common variants in FCER1A influence total serum IgE levels from cord blood up to six years of lifeC-M Chen, S Weidinger, N Klopp, et al.
Targeted Oncology|June 6, 2023
A Phase Ib Study Assessing the Safety, Tolerability, and Efficacy of the First-in-Class Wee1 Inhibitor Adavosertib (AZD1775) as Monotherapy in Patients with Advanced Solid TumorsTodd M Bauer, Kathleen N Moore, Janet S Rader, et al.
Physical Review Letters|August 13, 2016
Photoinduced Enhancement of the Charge Density Wave AmplitudeA Singer, S K K Patel, R Kukreja, et al.
JCI Insight|September 9, 2024
The histone methyltransferase Mixed-lineage-leukemia-1 drives T cell phenotype via Notch signaling in diabetic tissue repairWilliam J Melvin, Tyler M Bauer, Kevin D Mangum, et al.
JCI Insight|November 24, 2025
TNF-α represses fibroblast to myofibroblast transition through the histone methyltransferase Setdb2Tyler M Bauer, Kevin D Mangum, Samuel D Buckley, et al.
Cell Host & Microbe|January 9, 2025
Clec12a controls colitis by tempering inflammation and restricting expansion of specific commensalsTyson R Chiaro, Morgan Greenewood, Kaylyn M Bauer, et al.
Journal for Immunotherapy of Cancer|October 24, 2018
Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: the CheckMate 016 studyAsim Amin, Elizabeth R Plimack, Marc S Ernstoff, et al.
Pageof 250